Table 2.

Duration of responses

TotalPRCRPR + CR
All patients13920323 (17%)
Trial 154527 (13%)
    Duration (mo)4, 5, 43, 47+, 50+52+, 53+
Trial 28515116 (19%)
    Duration (mo)6, 6, 7, 9, 10, 10, 11, 17+, 17+, 18+, 19, 22+, 28+, 30+, 31+29+
  • NOTE: + indicates ongoing response.